Recently, CCL23 was demonstrated to promote the migration of human ovarian cancer cells in vitro by activating ERK1/2 and PI3K pathways and was hypothesized to be an important mediator of metastatic cell colonization in the omentum in advanced ovarian cancer patients [13]. This evidence concerns the gene MAPK3 and ovarian carcinoma.